Step 1 - Before enrolment, please:
- assess your patient's eligibility for our Warfarin Care program
according to our Eligibility criteria.
- provide your patient with adequate dosing instructions until
Warfarin Care Support have notified you and your patient that the
enrolment process is complete. Allow at least 3 working days.
Step 2 - Doctor, nurse, or practice manager
must fax the completed enrolment application to Warfarin Care
Support to enrol your patient. Please retain this original
enrolment application for future reference.
Your patient's eligibility will be assessed and we
will notify you if our program is not suitable for your
If your patient is in hospital, you must confirm their
enrolment is accepted before they are discharged.
The referring doctor must manage the patient's heparin therapy,
including low molecular weight heparin such as Clexane. Heparin
therapy (UF or LMWH) should continue until INR is in the
therapeutic range for at least 48 hours.
We cannot commence enrolments on Fridays, weekends, or
public holidays. Enrolment days will be limited prior to Easter,
Christmas and New Year to allow the safe transfer of your patient
onto our program.
Enrolment in our Warfarin Care program is contingent upon all
parties - doctor, patient, and laboratory - understanding and
accepting their roles and responsibilities as outlined in the
Sullivan Nicolaides Pathology Handbook for Doctors.
To be eligible for enrolment on our program, your patient
- be taking Warfarin (not Dindevan medication)
- have a minimum enrolment period of one month
- have a General Practitioner (includes patients discharged from
public hospital) who refers their patients to Sullivan Nicolaides
- have a valid contact phone number and mailing address
- be able to comprehend and record verbal dose instructions
- be able to comply with dose instructions (or has a carer who
- be able to attend for testing on scheduled dates, subject to
- not have been discharged from a Warfarin Care program due to
- not require a narrow target range (less than one unit)
- not require daily INR levels
- not require acute care
|ONGOING PATIENT ELIGIBILITY FOR WARFARIN
Patients who were eligible on enrolment will become ineligible
for our Warfarin Care program if they:
- require a narrow target range
- require daily INR levels
- are non-compliant
- become unable to follow verbal or written dose
- are abusive to Sullivan Nicolaides Pathology staff
- develop complex clinical conditions or become unstable where
one-on-one management by their own referring doctor is
- experience ongoing difficulties attending on scheduled test
dates - for example, patients who reside in remote areas or whose
employment requires frequent travel
You will be advised of our concerns regarding your patient's
suitability for our program. If these concerns are not not
resolved, then we will return the responsibility for managing your
patient's warfarin therapy to you.
Website - The Australasian Society of Thrombosis and